Inhibition of effector B cells by ibrutinib in systemic sclerosis

OBJECTIVE: Systemic sclerosis (SSc) is a connective tissue disease with a significant morbidity and reduced survival of patients. Effective treatment and clinical control of the disease remain challenging. In particular, the development of pulmonary and cardiac fibrosis and pulmonary hypertension ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Einhaus, Jakob, Pecher, Ann-Christin, Asteriti, Elisa, Schmid, Hannes, Secker, Kathy-Ann, Duerr-Stoerzer, Silke, Keppeler, Hildegard, Klein, Reinhild, Schneidawind, Corina, Henes, Joerg, Schneidawind, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106617/
https://www.ncbi.nlm.nih.gov/pubmed/32228672
http://dx.doi.org/10.1186/s13075-020-02153-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106617/
https://www.ncbi.nlm.nih.gov/pubmed/32228672
http://dx.doi.org/10.1186/s13075-020-02153-8

Ejemplares similares